Hero

Treatment & Adherence

Treatment guidelines for cystic fibrosis

This list is non-exhaustive

 European Union

 United Kingdom

 Brazil

  • Best practice guidelines by the European Cystic Fibrosis Society (ECFS), 2018

    This guideline is a revision of the ECFS best practice guidelines published in 2014, updating standards for best practice in key aspects of cystic fibrosis care.
  • Cystic fibrosis: diagnosis and management, 2017

    The National Institute for Health and Care Excellence (NICE) guideline [NG78]

    This guideline covers diagnosis and management of cystic fibrosis. It specifies how to monitor the condition and manage the symptoms to improve quality of life.This summary article of the guideline NG78 has been reviewed and approved by NICE, and is available in different languages:

    Brazilian (Portuguese) | English | German | Spanish | Polish

  • Brazilian guidelines for the diagnosis and treatment of cystic fibrosis, 2017

    These guidelines from Grupo Brasileiro de Estudos de Fibrose Cística aggregate key scientific evidence to guide the management of patients across Brazil.

 United States

  • Cystic fibrosis pulmonary guidelines, 2013

    Chronic medications for maintenance of lung health

     

    Systematic review of guidelines by the Pulmonary Clinical Practice Guidelines Committee on chronic medications for the maintenance of lung health.

  • Cystic fibrosis adult care, 2004

    Consensus conference report

     

    Systematic review of guidelines by the Pulmonary Clinical Practice Guidelines Committee on chronic medications for the maintenance of lung health.

  • Cystic Fibrosis Foundation pulmonary guidelines, 2018

    Use of cystic fibrosis transmembrane conductance regulator modulator therapy in patients with cystic fibrosis

     

    Cystic Fibrosis Foundation clinical practice guidelines endorsed by the American Thoracic Society.

Welcome to Medically

The Roche Science Hub

This website is a non-promotional global resource intended to facilitate transparent scientific exchange regarding developments in medical research, diagnostics, and disease management. It is intended for healthcare professionals.

Not a healthcare professional? Browse:

This global website is intended for healthcare professionals outside the UK, US and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same.

You are Leaving Medically

By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.